TMO Thermo Fisher Stock Outlook 2026: The Price of Owning Science Infrastructure
Thermo Fisher Scientific (TMO) stock analysis for 2026: $45.2B TTM revenue, P/E 24.6x, CDMO recovery cycle, NIH budget headwinds, analyst target $611, and what the 30% drop from highs actually means for investors.
TMO Thermo Fisher Life Sciences